Westlake Corporation

Westlake trades at a striking 10.5% short interest—meaningfully elevated for a chemical maker—yet sits 53 RSI points away from overbought territory, suggesting conviction skeptics haven't capitulated. The absence of a P/E ratio flags profitability concerns or valuation opacity that warrant scrutiny. At $15.2B market cap, the stock remains well below its 52-week peak despite industrial chemicals' cyclical recovery tailwinds. This combination—elevated shorts, mid-range momentum, and an unproven earnings picture—creates classic squeeze conditions if sentiment shifts, though the short position's persistence hints at legitimate fundamental worries the bulls haven't fully addressed.